KORU Medical Systems, Inc.
KRMD Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 27, 2026
$3.17
KIRA · Stoqly’s AI analyst, in plain words
- KORU Medical Systems, Inc. had $41.1M of revenue in fiscal 2025, up 22.2% on the year before. Over five years, revenue changed +11.2% a year on average.
- Its operating margin was −7.2%, up 11.9 pts: of every 100 in sales, about −7 is left after running the business.
- KORU Medical Systems, Inc. lost $2.6M in fiscal 2025.
- Free cash flow was −$0.5M in fiscal 2025, −1.1% of revenue.
Market cap
$157M
P/E
—
Revenue
$41.1M
Net income
−$2.6M
Free cash flow
−$0.5M
Operating margin
−7.2%
KORU Medical Systems, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+22.2%
Yes. Sales grew 22.2% last year.
Does it make a profit?
−6.4%
No. It lost money last year.
Does profit turn into cash?
−1.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What KORU Medical Systems, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 12, 2026
- Legal name
- KORU Medical Systems, Inc.
- CIK
- 0000704440
KORU Medical Systems, Inc. · KRMD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $23.5M | $27.9M | $28.5M | $33.6M | $41.1M |
| Revenue growth | −2.8% | 18.8% | 2.2% | 18.0% | 22.2% |
| Gross margin | 58.6% | 55.1% | 58.6% | 63.4% | 62.3% |
| Operating margin | −29.9% | −38.6% | −36.0% | −19.2% | −7.2% |
| Net income | −$4.6M | −$8.7M | −$13.7M | −$6.1M | −$2.6M |
| Net margin | −19.4% | −31.0% | −48.2% | −18.0% | −6.4% |
| Diluted EPS | −$0.10 | −$0.19 | −$0.30 | −$0.13 | −$0.06 |
| Cash | |||||
| Cash from operations | −$4.3M | −$5.4M | −$4.9M | −$0.3M | $0.5M |
| Capital expenditure | $0.3M | $2.8M | $0.8M | $1.3M | $0.9M |
| Free cash flow | −$4.7M | −$8.2M | −$5.7M | −$1.6M | −$0.5M |
| FCF margin | −19.9% | −29.3% | −19.9% | −4.8% | −1.1% |
| Share count change | 5.9% | 1.4% | 1.3% | 0.4% | 0.8% |
| Debt and strength | |||||
| Cash and short-term investments | $25.3M | $17.4M | $11.5M | $9.6M | $8.9M |
| Shareholders' equity | $36.5M | $31.3M | $20.4M | $16.8M | $17.0M |
| Current ratio | 7.8x | 4.3x | 4.5x | 2.7x | 2.4x |
| Returns and quality | |||||
| Return on equity | −12.6% | −25.5% | −53.2% | −32.6% | −15.6% |
| Return on tangible equity | −12.8% | −28.4% | −70.1% | −37.7% | −16.1% |
| Piotroski F-score | 1 | 2 | 4 | 4 | 4 |
| Altman Z'' | 11.9 | 4.1 | 1.2 | −0.5 | −0.1 |
Insiders bought, 12 months
$1.6M
5 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
KORU Medical Systems, Inc. · KRMD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.17 a share, the company is worth $157M.
Source: SEC EDGAR XBRL filings (CIK 0000704440). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.